Literature DB >> 7989532

Gas chromatographic determination of D-arabinitol/L-arabinitol ratios in urine: a potential method for diagnosis of disseminated candidiasis.

L Larsson1, C Pehrson, T Wiebe, B Christensson.   

Abstract

A gas chromatographic procedure was developed to determine the relative amounts of D- and L-arabinitol in urine. Samples were filtered, diluted, purified through extractions, evaporated, and treated with trifluoroacetic anhydride; the arabinitol derivatives thus obtained were separated on a chiral stationary phase and registered by using an electron-capture detector. Urine samples from a patient with disseminated candidiasis had higher D-arabinitol/L-arabinitol ratios (referred to as D/L-arabinitol ratios)--up to 19.0--than samples from 96 study individuals with no signs of deep Candida infections (range, 1.1 to 4.5). D/L-Arabinitol ratios in urine samples from hospitalized patients without Candida infections were slightly higher than those in samples from healthy individuals; ratios in urine from children were slightly higher than those in adult urine samples. The D/L-arabinitol ratios in several urine samples culture positive for Candida albicans, but from patients without symptoms of disseminated candidiasis, did not differ from those in the urine of healthy individuals. The described gas chromatographic method is straightforward and can be implemented clinically to determine urine D/L-arabinitol ratios as a means of diagnosing disseminated candidiasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989532      PMCID: PMC263891          DOI: 10.1128/jcm.32.8.1855-1859.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

Review 1.  Fungal blood cultures.

Authors:  A Telenti; G D Roberts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

2.  Effects of gastrointestinal candidiasis, antibiotics, dietary arabinitol, and cortisone acetate on levels of the Candida metabolite D-arabinitol in rat serum and urine.

Authors:  B Wong; K L Brauer; J R Clemens; S Beggs
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  Serum arabinitol concentrations and arabinitol/creatinine ratios in invasive candidiasis.

Authors:  J W Gold; B Wong; E M Bernard; T E Kiehn; D Armstrong
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

4.  Enantioselective measurement of the Candida metabolite D-arabinitol in human serum using multi-dimensional gas chromatography and a new chiral phase.

Authors:  B Wong; M Castellanos
Journal:  J Chromatogr       Date:  1989-10-27

5.  Stereoisomeric configuration of arabinitol in serum, urine, and tissues in invasive candidiasis.

Authors:  E M Bernard; B Wong; D Armstrong
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

6.  Candidiasis: detection by gas-liquid chromatography of D-arabinitol, a fungal metabolite, in human serum.

Authors:  T E Kiehn; E M Bernard; J W Gold; D Armstrong
Journal:  Science       Date:  1979-11-02       Impact factor: 47.728

7.  An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species.

Authors:  A C Switchenko; C G Miyada; T C Goodman; T J Walsh; B Wong; M J Becker; E F Ullman
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

8.  The arabinitol appearance rate in laboratory animals and humans: estimation from the arabinitol/creatine ratio and relevance to the diagnosis of candidiasis.

Authors:  B Wong; E M Bernard; J W Gold; D Fong; D Armstrong
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

9.  Role of individual serum pentitol concentrations in the diagnosis of disseminated visceral candidiasis.

Authors:  J Roboz; D C Kappatos; J F Holland
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

10.  Two-dimensional gas chromatography with electron capture detection for the sensitive determination of specific mycobacterial lipid constituents.

Authors:  L Larsson; J Jimenez; A Sonesson; F Portaels
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

View more
  7 in total

1.  Diagnosis of invasive candidiasis in neutropenic children with cancer by determination of D-arabinitol/L-arabinitol ratios in urine.

Authors:  B Christensson; T Wiebe; C Pehrson; L Larsson
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 2.  Use of gas chromatography-ion trap tandem mass spectrometry for the detection and characterization of microorganisms in complex samples.

Authors:  L Larsson; A Saraf
Journal:  Mol Biotechnol       Date:  1997-06       Impact factor: 2.695

Review 3.  Clinical and laboratory diagnosis of invasive candida infection in neutropenic patients.

Authors:  M Kalin; B Petrini
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

4.  Diagnosis of disseminated candidiasis by measurement of urine D-arabinitol/L-arabinitol ratio.

Authors:  L Lehtonen; V J Anttila; T Ruutu; J Salonen; J Nikoskelainen; E Eerola; P Ruutu
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  Measurement of serum D-arabinitol/creatinine ratios for initial diagnosis and for predicting outcome in an unselected, population-based sample of patients with Candida fungemia.

Authors:  Siew Fah Yeo; Sharon Huie; Andre N Sofair; Sheldon Campbell; Amanda Durante; Brian Wong
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

6.  Urine D-arabinitol/L-arabinitol ratio in diagnosis of invasive candidiasis in newborn infants.

Authors:  G Sigmundsdóttir; B Christensson; L J Björklund; K Håkansson; C Pehrson; L Larsson
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

7.  A novel molecular imprinting polymer for the selective adsorption of D-arabinitol from spiked urine.

Authors:  Yuni Retnaningtyas; Ganden Supriyanto; Ni Nyoman Tri Puspaningsih; Roedi Irawan; Siswandono Siswodihardjo
Journal:  Turk J Chem       Date:  2020-10-26       Impact factor: 1.239

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.